Anakinra vs Canakinumab

Interacting Drugs
Anakinra
vs
Canakinumab
Security Level
Major, Avoid combination
Mechanism
Canakinumab: Interleukin-1 Receptor Antagonist may enhance the adverse/toxic effect of Canakinumab. Whether such a combination will also alter the therapeutic response to one or both agents is unclear.
Management
Avoid combination

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Anakinra vs Canakinumab


Other Interactions of Anakinra

We are Developing Our database, More results coming soon.

Other Interactions of Canakinumab

We are Developing Our database, More results coming soon.